Login Register Cart 0
Generic placeholder image

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Effect of Transcranial Pulse Stimulation for the Treatment of Alzheimer´s Disease and its Related Symptoms

Author(s): Ramiro Fernández-Castaño, Miguel Ángel Fernández-Blázquez*, Iria Echevarría Fernández, Manuela Cabrera-Freitag and Karin Freitag

Volume 20, Issue 4, 2023

Published on: 08 August, 2023

Page: [244 - 249] Pages: 6

DOI: 10.2174/1567205020666230727102025

Price: $65

Abstract

Alzheimer's disease (AD) is the most common cause of neurodegenerative cognitive impairment. Brain stimulation techniques based on the delivery of transcranial shockwaves are currently being studied for their increasing popularity as an approach to modulate the human brain in a focal and targeted manner making this therapy a promising line of action against AD. In the present manuscript, we review for further understanding whether transcranial pulse stimulation (TPS) is a beneficial treatment for AD patients. PubMed, Google Scholar, and Cochrane databases were accessed with the search criteria set from year 2001 to 2022 and the following keywords were used: “transcranial pulse stimulation”, “focused ultrasound”, “noninvasive treatment and Alzheimer” and “TPS”. The search was focused on papers that provide evidence on the biological bases of the method, as well as its safety and tolerability. Even though more studies are needed with greater scientific rigor, such as a doubleblind and randomized study versus a placebo, TPS is an excellent and safe therapeutic option for AD. This novel approach accompanies currently available treatments and complements them, helping to maintain greater stability of the disease and slowing its progression. The biological effects and potential mechanisms of action of TPS for the improvement of cognitive function are further discussed.

« Previous Next »
[1]
Abeysinghe AADT, Deshapriya RDUS, Udawatte C. Alzheimer’s disease: A review of the pathophysiological basis and therapeutic interventions. Life Sci 2020; 256: 117996.
[http://dx.doi.org/10.1016/j.lfs.2020.117996] [PMID: 32585249]
[2]
Thal DR, Griffin WST, de Vos RAI, Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease. Acta Neuropathol 2008; 115(6): 599-609.
[http://dx.doi.org/10.1007/s00401-008-0366-2] [PMID: 18369648]
[3]
Jack CR Jr, Bennett DA, Blennow K, et al. NIA‐AA research framework: Toward a biological definition of alzheimer’s disease. Alzheimers Dement 2018; 14(4): 535-62.
[http://dx.doi.org/10.1016/j.jalz.2018.02.018] [PMID: 29653606]
[4]
2021 Alzheimer’s disease facts and figures. Alzheimers Dement 2021; 17(3): 327-406.
[http://dx.doi.org/10.1002/alz.12328] [PMID: 33756057]
[5]
Francis PT, Ramírez MJ, Lai MK. Neurochemical basis for symptomatic treatment of Alzheimer’s disease. Neuropharmacology 2010; 59(4-5): 221-9.
[http://dx.doi.org/10.1016/j.neuropharm.2010.02.010] [PMID: 20156462]
[6]
Krishna V, Sammartino F, Rezai A. A review of the current therapies, challenges, and future directions of transcranial focused ultrasound technology. JAMA Neurol 2018; 75(2): 246-54.
[http://dx.doi.org/10.1001/jamaneurol.2017.3129] [PMID: 29228074]
[7]
Beisteiner R, Lozano AM. Transcranial ultrasound innovations ready for broad clinical application. Adv Sci 2020; 7(23): 2002026.
[http://dx.doi.org/10.1002/advs.202002026] [PMID: 33304757]
[8]
Aryal M, Arvanitis CD, Alexander PM, McDannold N. Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous system. Adv Drug Deliv Rev 2014; 72: 94-109.
[http://dx.doi.org/10.1016/j.addr.2014.01.008] [PMID: 24462453]
[9]
Saxena V, Pal A. Role of transcranial direct current stimulation in the management of alzheimer’s disease: A meta-analysis of effects, adherence and adverse effects. Clin Psychopharmacol Neurosci 2021; 19(4): 589-99.
[http://dx.doi.org/10.9758/cpn.2021.19.4.589] [PMID: 34690114]
[10]
Weiler M, Stieger KC, Long JM, Rapp PR. Transcranial magnetic stimulation in alzheimer's disease: Are we ready? eNeuro 2020; 7(1): eNEURO.0235-19.
[http://dx.doi.org/10.1523/ENEURO.0235-19.2019]
[11]
Minjoli S, Saturnino GB, Blicher JU, et al. The impact of large structural brain changes in chronic stroke patients on the electric field caused by transcranial brain stimulation. Neuroimage Clin 2017; 15: 106-17.
[http://dx.doi.org/10.1016/j.nicl.2017.04.014] [PMID: 28516033]
[12]
Spagnolo PA, Wang H, Srivanitchapoom P, Schwandt M, Heilig M, Hallett M. Lack of target engagement following low-frequency deep transcranial magnetic stimulation of the anterior insula. Neuromodulation 2019; 22(8): 877-83.
[http://dx.doi.org/10.1111/ner.12875] [PMID: 30370983]
[13]
Legon W, Ai L, Bansal P, Mueller JK. Neuromodulation with single-element transcranial focused ultrasound in human thalamus. Hum Brain Mapp 2018; 39(5): 1995-2006.
[http://dx.doi.org/10.1002/hbm.23981] [PMID: 29380485]
[14]
Beisteiner R. Human ultrasound neuromodulation: State of the art. Brain Sci 2022; 12(2): 208.
[http://dx.doi.org/10.3390/brainsci12020208] [PMID: 35203971]
[15]
Beisteiner R, Matt E, Fan C, et al. Transcranial pulse stimulation with ultrasound in alzheimer’s disease-a new navigated focal brain therapy. Adv Sci 2020; 7(3): 1902583.
[http://dx.doi.org/10.1002/advs.201902583] [PMID: 32042569]
[16]
Dörl G, Matt E, Beisteiner R. Functional specificity of TPS brain stimulation effects in patients with alzheimer’s disease: A follow-up fMRI analysis. Neurol Ther 2022; 11(3): 1391-8.
[http://dx.doi.org/10.1007/s40120-022-00362-8] [PMID: 35633496]
[17]
Cont C, Stute N, Galli A, et al. Retrospective real-world pilot data on transcranial pulse stimulation in mild to severe Alzheimer’s patients. Front Neurol 2022; 13: 948204.
[http://dx.doi.org/10.3389/fneur.2022.948204] [PMID: 36188380]
[18]
Novak P, Lohse-Busch HP. 31 long-term results with TPS (transcranial pulse stimulation) treatment of alzheimer’s disease. Clin Neurophysiol 2022; 137: e32-3.
[http://dx.doi.org/10.1016/j.clinph.2022.01.062]
[19]
Matt E, Dörl G, Beisteiner R. Transcranial pulse stimulation (TPS) improves depression in AD patients on state‐of‐the‐art treatment. Alzheimers Dement 2022; 8(1): e12245.
[http://dx.doi.org/10.1002/trc2.12245] [PMID: 35169611]
[20]
Radjenovic S, Dörl G, Gaal M, Beisteiner R. Safety of clinical ultrasound neuromodulation. Brain Sci 2022; 12(10): 1277.
[http://dx.doi.org/10.3390/brainsci12101277] [PMID: 36291211]
[21]
Sanguinetti JL, Hameroff S, Smith EE, et al. Transcranial focused ultrasound to the right prefrontal cortex improves mood and alters functional connectivity in humans. Front Hum Neurosci 2020; 14: 52.
[http://dx.doi.org/10.3389/fnhum.2020.00052] [PMID: 32184714]
[22]
Beccaria K, Sabbagh A, de Groot J, Canney M, Carpentier A, Heimberger AB. Blood–brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors. J Neurooncol 2021; 151(1): 65-73.
[http://dx.doi.org/10.1007/s11060-020-03425-8] [PMID: 32112296]
[23]
Callahan CM, Apostolova LG, Gao S, et al. Novel markers of angiogenesis in the setting of cognitive impairment and dementia. J Alzheimers Dis 2020; 75(3): 959-69.
[http://dx.doi.org/10.3233/JAD-191293] [PMID: 32390626]
[24]
Jordão JF, Ayala-Grosso CA, Markham K, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer’s disease. PLoS One 2010; 5(5): e10549.
[http://dx.doi.org/10.1371/journal.pone.0010549] [PMID: 20485502]
[25]
Zhang J, Kang N, Yu X, Ma Y, Pang X. Radial extracorporeal shock wave therapy enhances the proliferation and differentiation of neural stem cells by notch, PI3K/AKT, and Wnt/β-catenin signaling. Sci Rep 2017; 7(1): 15321.
[http://dx.doi.org/10.1038/s41598-017-15662-5] [PMID: 29127399]
[26]
Jordão JF, Thévenot E, Markham-Coultes K, et al. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol 2013; 248: 16-29.
[http://dx.doi.org/10.1016/j.expneurol.2013.05.008] [PMID: 23707300]
[27]
Leinenga G, Götz J. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model. Sci Transl Med 2015; 7(278): 278ra33.
[http://dx.doi.org/10.1126/scitranslmed.aaa2512] [PMID: 25761889]
[28]
Lin WT, Chen RC, Lu WW, Liu SH, Yang FY. Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer’s disease rat model. Sci Rep 2015; 5(1): 9671.
[http://dx.doi.org/10.1038/srep09671] [PMID: 25873429]
[29]
Popescu T, Pernet C, Beisteiner R. Transcranial ultrasound pulse stimulation reduces cortical atrophy in Alzheimer’s patients: A follow‐up study. Alzheimers Dement 2021; 7(1): e12121.
[http://dx.doi.org/10.1002/trc2.12121] [PMID: 33681449]
[30]
Jones BN, Reifler BV. Depression coexisting with dementia: Evaluation and Treatment. Med Clin North Am 1994; 78(4): 823-40.
[http://dx.doi.org/10.1016/S0025-7125(16)30136-5] [PMID: 8022231]
[31]
Xu Y, Zhao M, Han Y, Zhang H. GABAergic inhibitory interneuron deficits in alzheimer’s disease: Implications for treatment. Front Neurosci 2020; 14: 660.
[http://dx.doi.org/10.3389/fnins.2020.00660] [PMID: 32714136]
[32]
Wu Z, Guo Z, Gearing M, Chen G. Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer’s disease model. Nat Commun 2014; 5(1): 4159.
[http://dx.doi.org/10.1038/ncomms5159] [PMID: 24923909]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy